Elevated DNMT1 expression in DKD mononuclear cells induces mTOR-related methylation changes and inflammation, reversible through DNMT1 inhibition with 5-aza-2′-deoxycytidine (5-aza), offering a new therapeutic perspective [175]. This evidence concerns the gene MTOR and diabetic kidney disease.